CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
CURIS, INC. (CRIS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-19.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2020-03-19
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-03-31 was 0.00%.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2018-03-31 was 0.00%.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2017-03-31 was 0.00%.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2016-03-31 was 0.00%.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2019 was 0.00%.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2018 was 0.00%.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2017 was 0.00%.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2016 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | 0.00% 10-K · filed 2020-03-19 | ||||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-05 | ||||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-09 | ||||
| 2019-03-31 | 0.00% 10-Q · filed 2019-05-14 | ||||
| 2018-12-31 | 0.00% 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | 0.00% 10-Q · filed 2019-11-05 | ||||
| 2018-06-30 | 0.00% 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | 0.00% 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2019-03-26 | ||||
| 2017-06-30 | 0.00% 10-Q · filed 2017-08-03 | ||||
| 2017-03-31 | 0.00% 10-Q · filed 2017-05-04 | ||||
| 2016-12-31 | 0.00% 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | 0.00% 10-Q · filed 2016-11-03 | ||||
| 2016-06-30 | 0.00% 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | 0.00% 10-Q · filed 2017-05-04 | ||||
| 2015-12-31 | 0.00% 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | 0.00% 10-Q · filed 2016-11-03 | ||||
| 2015-06-30 | 0.00% 10-Q · filed 2016-08-04 | ||||
| 2015-03-31 | 0.00% 10-Q · filed 2016-05-09 | ||||
| 2014-12-31 | 0.00% 10-K · filed 2017-03-09 | ||||
| 2014-09-30 | 0.00% 10-Q · filed 2015-11-09 | ||||
| 2014-06-30 | 0.00% 10-Q · filed 2015-08-06 | ||||
| 2014-06-02 | 0.00% 10-K · filed 2018-03-08 | ||||
| 2014-02-18 | 0.00% 10-K · filed 2018-03-08 | ||||
| 2013-12-31 | 0.00% 10-K · filed 2016-02-29 | ||||
| 2012-12-31 | 0.00% 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |